T cell receptor (TCR) therapy is an innovative form of cancer treatment that involves modifying a patient's T cells to recognize and attack cancer cells. TCR therapy leverages the body's own immune system to target specific antigens presented on the surface of cancer cells. Unlike other forms of immunotherapy, TCR therapy relies on the precision of T cell receptors to identify and bind to these antigens, which are often unique to cancerous cells.
